Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Surgical Equipment

Ambu VivaSight 2 DLT Endobronchial Tubes Recalled for Airway Injury Risk

Agency Publication Date: October 30, 2024
Share:
Sign in to monitor this recall

Summary

Ambu Inc. has recalled 1,824 VivaSight 2 DLT Endobronchial tubes because the tip of the tube (the distal end) may be bent too sharply, a condition known as hyper angulation. This defect can make the intubation process difficult and poses a significant risk of injuring the patient's airway during medical procedures. The recall affects four different sizes (35 Fr, 37 Fr, 39 Fr, and 41 Fr) distributed across the United States and Canada.

Risk

If the tube is bent at an excessive angle, it can cause physical trauma or airway injury as it is inserted into the patient. Ambu has received reports of hyper angulation complaints, though no specific injury counts were detailed in the current data.

What You Should Do

  1. This recall affects Ambu VivaSight 2 DLT Endobronchial tubes in sizes 35 Fr, 37 Fr, 39 Fr, and 41 Fr (Catalog Numbers 412351000, 412371000, 412391000, and 412411000).
  2. Check the lot numbers printed on your device packaging to see if your product is affected. Impacted lot ranges include: 1000891667 to 1001021855 (35 Fr); 1000887909 to 1001021861 (37 Fr); 1000916871 to 1001021917 (39 Fr); and 1000934084 to 1001011434 (41 Fr). See the Affected Products section below for the full list of affected codes.
  3. Stop using the recalled device immediately.
  4. Contact Ambu Inc. or your medical distributor to arrange for the return, replacement, or correction of the affected tubes.
  5. Call the FDA at 1-888-INFO-FDA (1-888-463-6332) for further information regarding medical device recalls.

Your Remedy Options

📋Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Ambu VivaSight 2 DLT Endobronchial tube
Variants: 35 Fr, 37 Fr, 39 Fr, 41 Fr
Model / REF:
412351000
412371000
412391000
412411000
Lot Numbers:
1000891667 to 1001021855 (35 Fr)
1000887909 to 1001021861 (37 Fr)
1000916871 to 1001021917 (39 Fr)
1000934084 to 1001011434 (41 Fr)

Recall #: Z-0261-2025

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 95454
Status: Active
Manufacturer: Ambu Inc.
Sold By: Ambu Inc.; Medical distributors
Manufactured In: United States
Units Affected: 1824
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.